Cardiotocography (CTG)

How Cardiotocography Helps Assess Fetal Heart Rate

The visual representation of uterine contractions and FHR is called cardiotocography. Cardiotocographic monitoring is thought to be crucial, yet there is a lot of difference in practice and the suggested amount of time for monitoring. It may be impossible to diagnose premature labor and placental abruption without continuing continuous monitoring for a minimum of six hours, and maybe up to twenty-four hours, as needed. Cardiotocography (CTG) is a commonly utilized modality in labor and delivery for the detection of fetal hypoxia. It is possible to visually assess the fetal heart rate (FHR) pattern by characterizing its baseline, variability, and cyclical variations. Fetal heart rate rises when there is a decrease in baseline variation in fetal hypoxia.

Cardiotocography (CTG) – Estimated Cost

The cost of a CTG test can vary depending on the healthcare provider, hospital, and geographic location. Below are approximate estimated costs for Cardiotocography (CTG) in India, Turkey, Thailand, and Dubai:

Note: These costs are approximate and may vary depending on the hospital, medical team, and any additional tests required. For an accurate cost of cardiotocography in India and personalized guidance, please contact EdhaCare.

Best Hospitals in India for Cardiotocography (CTG)

EdhaCare helps patients find the best hospitals in India for cardiotocography . We connect you with top hospitals for CTG in India offering advanced fetal monitoring technology and expert maternity care.

Expert Doctors in India for Cardiotocography (CTG)

Through EdhaCare, connect with the best doctors in India for cardiotocography. These top doctors for CTG in India provide accurate fetal assessment and personalized care.

Cardiotocography Uses:

Cardiotocography (CTG) is a crucial tool in obstetrics for tracking the health of the fetus. This is particularly done to:  

• Monitor the Fetal Heart Rate: The CTG continuously records the fetal heart rate, yielding vital clues as to fetal status.  
• Monitor Uterine Contractions: It can also record and assess uterine contractions from the mother's perspective, giving health-care personnel the ability to assess the progress of labor and the response of the fetus to contractions.  
• Determine Fetal Well-being: By analyzing patterns of fetal heart-rate changes concerning uterine contractions, health personnel can ascertain the signs of fetal distress, as in the case of hypoxia. 
• Pregnancy and Labor: Fetal well-being is monitored by CTG before and during the labor process, such evaluation being a predictor of the baby's health state. 

Cardiotocography (CTG) Treatment Procedure

CTG monitoring is widely used to assess fetal well-being by identifying babies at risk of hypoxia (lack of oxygen). 

• Preparation: The healthcare provider explains the procedure to the expectant mother and ensures her comfort during the test. The woman is positioned comfortably on her back or side, depending on gestational age and individual comfort.
• Application of Transducers: Two transducers are placed on the woman's abdomen. The first transducer, the ultrasound transducer, is positioned over the area where the fetal heart rate is best heard. The second transducer, the toco transducer, is placed over the fundus of the uterus to measure uterine contractions.
• Monitoring: The CTG machine records the fetal heart rate and uterine contractions continuously for a specific duration, usually 20-30 minutes. The machine produces a graph (trace) that shows the changes in fetal heart rate and uterine contractions over time.
• Interpretation: The CTG trace is analyzed by the healthcare provider to assess fetal well-being. They examine various parameters, including baseline fetal heart rate, variability, accelerations, decelerations, and the relationship between fetal heart rate and contractions.
• Assessment of Variability and Patterns: Variability refers to the normal fluctuations in the fetal heart rate, which indicates a healthy nervous system. Patterns, such as accelerations (temporary increases in heart rate) and decelerations (temporary decreases in heart rate), are also evaluated for normalcy.
• Non-Reactive Traces: If the CTG trace shows no significant variability or abnormal patterns, it is considered non-reactive. Further assessment or additional tests may be necessary to evaluate fetal well-being more closely.
• Documentation and Communication: The findings of the CTG monitoring are documented in the woman's medical records, and the results are communicated to the woman and her healthcare team. Further actions, such as additional testing, changes in management, or further monitoring, may be recommended based on the CTG findings.